A detailed history of Bell Investment Advisors, Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 55 shares of GH stock, worth $1,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Previous 55 -0.0%
Holding current value
$1,795
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$16.07 - $31.84 $883 - $1,751
55 New
55 $1,000
Q1 2023

May 10, 2023

BUY
$22.92 - $33.76 $137 - $202
6 Added 46.15%
19 $0
Q4 2022

Feb 08, 2023

SELL
$25.44 - $59.78 $356 - $836
-14 Reduced 51.85%
13 $0
Q2 2022

Aug 12, 2022

BUY
$28.82 - $77.35 $634 - $1,701
22 Added 440.0%
27 $1,000
Q4 2021

Feb 14, 2022

SELL
$88.71 - $120.43 $887 - $1,204
-10 Reduced 66.67%
5 $1,000
Q3 2021

Nov 12, 2021

BUY
$98.77 - $132.17 $1,481 - $1,982
15 New
15 $2,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.